Table 1.
Group | Mean | Kruskal—Wallis | KN | K- | P100 | P200 | P400 | P600 | P800 |
---|---|---|---|---|---|---|---|---|---|
KN | 46.200 | 0.000 | 0.007 ** | 0.008 ** | 0.008 ** | 0.008 ** | 0.001 ** | 0.002 ** | |
K- | 81.700 | 0.189 ns | 0.015 * | 0.012 * | 0.006 ** | 0.006 ** | |||
P100 | 78.100 | 0.343 ns | 0.192 | 0.008 ** | 0.008 ** | ||||
P200 | 61.200 | 0.343 | 0.006 ** | 0.006 ** | |||||
P400 | 58.900 | 0.008 ** | 0.008 ** | ||||||
P600 | 50.100 | 0.180 ns | |||||||
P800 | 48.100 |
KN: normal rats, K-: doxorubicin 15 mg/kgbw, P1: 100 mg/kgbw + doxorubicin, P2: 200 mg/kgbw + doxorubicin, P3: 400 mg/kgbw + doxorubicin, P4: 600 mg/kgbw + doxorubicin, P5: 800 mg/kgbw + doxorubicin. (*: p < 0.05, **: p < 0.01, p > 0.05 ns/not significance).